{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:24:50Z","timestamp":1790112290816,"version":"4.0.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Federation President Grant for Young Scientists","award":["\u041c\u041a-913.2017.4"],"award-info":[{"award-number":["\u041c\u041a-913.2017.4"]}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["16-14-00-224"],"award-info":[{"award-number":["16-14-00-224"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["17-74-10-224"],"award-info":[{"award-number":["17-74-10-224"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0199900","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T13:59:43Z","timestamp":1530194383000},"page":"e0199900","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Thrombodynamics\u2014A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment"],"prefix":"10.1371","volume":"13","author":[{"given":"Anna N.","family":"Balandina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya I.","family":"Serebriyskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Poletaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry M.","family":"Polokhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Gracheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-6726","authenticated-orcid":true,"given":"Ekaterina M.","family":"Koltsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Vardanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Taranenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey Yu.","family":"Krylov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokiya S.","family":"Urnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5358-7218","authenticated-orcid":true,"given":"Kirill V.","family":"Lobastov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem V.","family":"Chernyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Shulutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey P.","family":"Momot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Shulutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazoil I.","family":"Ataullakhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/026765919901400606","article-title":"Predictors for heparin resistance in patients undergoing coronary artery bypass grafting","volume":"14","author":"M Ranucci","year":"1999","journal-title":"Perfusion"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0267659111412999","article-title":"Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass","volume":"26","author":"V Muedra","year":"2011","journal-title":"Perfusion"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1538-7933.2004.00648.x","article-title":"Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No","volume":"2","author":"H Bounameaux","year":"2004","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00002018-200528040-00005","article-title":"Safety profile of different low-molecular weight heparins used at therapeutic dose","volume":"28","author":"I Gouin-Thibault","year":"2005","journal-title":"Drug Saf"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003088-200342120-00003","article-title":"Pharmacodynamic and pharmacokinetic properties of enoxaparin: Implications for clinical practice","volume":"42","author":"J Fareed","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: Findings from the improve investigators","volume":"139","author":"H Decousus","year":"2011","journal-title":"Chest"},{"key":"ref7","first-page":"1760","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"115","author":"J Hirsh","year":"1999","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"SR Kahn","year":"2012","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"C Kearon","year":"2016","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/cc10581","article-title":"Does dalteparin PROTECT better than heparin?","volume":"15","author":"T Przybysz","year":"2011","journal-title":"Crit Care"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40265-015-0526-3","article-title":"Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy","volume":"76","author":"N van Es","year":"2016","journal-title":"Drugs"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1345\/aph.1R635","article-title":"Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin","volume":"47","author":"EA Price","year":"2013","journal-title":"Ann Pharmacother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0116835","article-title":"Monitoring low molecular weight heparins at therapeutic levels: Dose-responses of, and correlations and differences between aptt, anti-factor xa and thrombin generation assays","volume":"10","author":"O Thomas","year":"2015","journal-title":"PLoS One"},{"key":"ref14","first-page":"163","article-title":"Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of. Thromb Haemost","volume":"87","author":"M Greaves","year":"2002","journal-title":"Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of. Thromb Haemost"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4103\/0019-5049.100847","article-title":"Rhabdomyolysis complicating non-invasive blood pressure measurement","volume":"56","author":"C Srinivasan","year":"2012","journal-title":"Indian J Anaesth"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-7-14","article-title":"Application of basic and composite thrombelastography parameters in monitoring of the antithrombotic effect of the low molecular weight heparin dalteparin: an in vivo study","volume":"7","author":"R Artang","year":"2009","journal-title":"Thromb J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/bja\/75.1.27","article-title":"Effect of ketorolac, bupivacaine and low-dose heparin on thrombelastographic variables in vitro","volume":"75","author":"NM Gibbs","year":"1995","journal-title":"Br J Anaesth"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cca.2012.09.029","article-title":"Monitoring of unfractionated heparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent (PiCT<sup>\u00ae<\/sup>)","volume":"414","author":"E Schaden","year":"2012","journal-title":"Clin Chim Acta. Elsevier B.V."},{"key":"ref19","first-page":"932","article-title":"Thromboelastography for the monitoring of the antithrombotic effect of low-molecular-weight heparin after major orthopedic surgery","volume":"15","author":"N Tekkesin","year":"2015","journal-title":"Anadolu Kardiyol Derg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1309\/Q4AE-BMCW-CQ7J-NUVT","article-title":"Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation","volume":"113","author":"K Zmuda","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bjh.13193","article-title":"Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring","volume":"168","author":"P Chowdary","year":"2015","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1538-7836.2004.00798.x","article-title":"Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time","volume":"2","author":"R al Dieri","year":"2004","journal-title":"J Thromb Haemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2010.07.024","article-title":"Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with Calibrated Automated Thrombography","volume":"127","author":"M Hacquard","year":"2011","journal-title":"Thromb Res. Elsevier Ltd"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3109\/10428194.2015.1041385","article-title":"Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma","volume":"56","author":"MA Gracheva","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12185-014-1559-1","article-title":"Laboratory tests for coagulation system monitoring in a patient with \u03b2-thalassemia","volume":"99","author":"EA Seregina","year":"2014","journal-title":"Int J Hematol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MBC.0b013e328352e90e","article-title":"Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics","volume":"23","author":"NP Soshitova","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bcmd.2014.11.021","article-title":"Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria","volume":"54","author":"EA Seregina","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/sleep\/33.3.283","article-title":"The case-crossover study: A novel design in evaluating transient fatigue as a risk factor for road traffic accidents","volume":"33","author":"DA Lombardi","year":"2010","journal-title":"Sleep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1055\/s-2007-1004384","article-title":"Increased Anti-Xa Bioavailability for a Low Molecular Weight Heparin (PK 10169) Compared with Unfractionated Heparin","volume":"11","author":"L Bara","year":"1985","journal-title":"Semin Thromb Hemost"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mcp.2002.127114","article-title":"The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers","volume":"72","author":"GJ Sanderink","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.bpj.2011.08.034","article-title":"Positive feedback loops for factor V and factor VII activation supply sensitivity to local surface tissue factor density during blood coagulation","volume":"101","author":"AN Balandina","year":"2011","journal-title":"Biophys J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e87692","DOI":"10.1371\/journal.pone.0087692","article-title":"Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients","volume":"9","author":"E Lipets","year":"2014","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-4165(02)00278-7","article-title":"Hemophilia A and B are associated with abnormal spatial dynamics of clot growth","volume":"1572","author":"M V Ovanesov","year":"2002","journal-title":"Biochim Biophys Acta\u2014Gen Subj"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0037-1613437","article-title":"Effect of factor VIII on tissue factor-initiated spatial clot growth","volume":"89","author":"M V Ovanesov","year":"2003","journal-title":"Thromb Haemost"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1538-7836.2005.01128.x","article-title":"Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: Initiator cells do not regulate spatial growth rate","volume":"3","author":"M V Ovanesov","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.talanta.2017.12.055","article-title":"Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency","volume":"180","author":"EI Sinauridze","year":"2018","journal-title":"Talanta"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ccd.20355","article-title":"Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory","volume":"65","author":"TM Doherty","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.thromres.2012.07.017","article-title":"Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study","volume":"130","author":"Y Dargaud","year":"2012","journal-title":"Thromb Res. Elsevier Ltd"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/vec.12610","article-title":"Operator-based variability of equine thromboelastography","volume":"27","author":"K Thane","year":"2017","journal-title":"J Vet Emerg Crit Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral Anticoagulants","volume":"141","author":"DA Garcia","year":"2012","journal-title":"Chest"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.15360\/1813-9779-2015-4-51-59","article-title":"Diagnosis of Impairments in the Hemostatic System in the Use of Warfarin in Cardiac Surgical Patients","volume":"11","author":"EI Goncharova","year":"2015","journal-title":"Gen Reanimatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1529\/biophysj.105.069062","article-title":"Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively","volume":"90","author":"MA Panteleev","year":"2006","journal-title":"Biophys J"},{"key":"ref43","first-page":"325","article-title":"Web-Bootstrap Estimate of Area Under ROC Curve","volume":"35","author":"H Skalsk\u00e1","year":"2006","journal-title":"Austrian J Stat"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archinte.161.3.385","article-title":"Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin","volume":"161","author":"SM Bates","year":"2001","journal-title":"Arch Intern Med"},{"key":"ref45","first-page":"975","article-title":"Evaluation of the Activated Partial Thromboplastin Time (APTT) Sensitivity to Heparin Using Five Commercial Reagents: Implications for Therapeutic Monitoring","volume":"36","author":"F Manzato","year":"1998","journal-title":"Evaluation of the Activated Partial Thromboplastin Time (APTT) Sensitivity to Heparin Using Five Commercial Reagents: Implications for Therapeutic Monitoring"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-2004-831050","article-title":"Recombinant platelet factor 4 for heparin neutralization","volume":"30","author":"TA Mixon","year":"2004","journal-title":"Semin Thromb Hemost"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0199900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:09:51Z","timestamp":1540210191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0199900"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0199900","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]}}}